Market News

Assured Guaranty reported third quarter 2026 revenue of US$214 million and net income of US$78 million, alongside adjusted earnings of US$1.94 per sha...

Dana (DAN) just delivered third quarter numbers that combined higher sales and stronger EBITDA margins with a lift to full year 2026 revenue guidance,...

American Electric Power Company (AEP) recently reorganized part of its business and created a new AEP Infrastructure unit to focus on energy projects ...

AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 3.3% on an annualized basis producing an average annual return of 16.33%. Cur...

Eurozone bank regulation is back in the spotlight, as policymakers push harder for a common deposit insurance scheme and smoother capital flows inside...

October payrolls beat forecasts, but mixed labor data and sticky inflation may keep the Fed steady. Click here to read this latest analysis.

Moderna (NASDAQ:MRNA) raised its 2026 revenue growth outlook after reporting higher third-quarter sales and a return to quarterly profitability, as de...

Regions Financial (NYSE:RF) expects its branch count to remain roughly flat even as it opens 135 to 150 locations, Chief Financial Officer Anil Chadha...

Appian (APPN) exhibits robust price momentum, recently hitting a new 3-year high. Shares are up nearly 40% over the past year. Technical indicators ar...

Kyivstar Group (NASDAQ:KYIV) raised its 2026 outlook after third-quarter revenue increased 18% to $349 million, helped by growth in its digital busine...

Fidus Investment (NASDAQ:FDUS) reported adjusted net investment income of $0.54 per share for the third quarter of 2026, up from $0.50 in the prior qu...

Calumet (NASDAQ:CLMT) reported $347 million in third-quarter adjusted EBITDA with tax attributes, as tight specialty products supplies and a strong qu...

Charter Communications (NASDAQ:CHTR) is overhauling its operations and targeting $2 billion in additional annualized cost savings after losing interne...

DraftKings (NASDAQ:DKNG) cut its 2026 revenue and adjusted earnings outlook after stepping up investment in its Predictions offering, even as third-qu...

Bloomin' Brands (NASDAQ:BLMN) raised the lower end of its full-year adjusted earnings forecast even as third-quarter traffic fell and the restaurant o...

Anika Therapeutics (NASDAQ:ANIK) reported a 10% increase in third-quarter revenue and raised the lower end of its 2026 revenue and adjusted EBITDA mar...

Sales rebounded in October, and management is shifting focus to store profitability.

Debt reduction and cost pressures defined a quarter of lower sales.

Gene therapy demand stabilizes while siRNA readouts and FDA talks loom ahead.

Record net new ARR and a retention milestone shaped the quarter.